A total of 11% of RSV patients experienced a cardiac event, abnormal heart rhythm, heart failure, or ischemic heart disease.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
(CIDRAP News) – As attention shifts to China and a novel H7N9 strain of avian flu, seasonal influenza in the United States continued to ebb, the US Centers for Disease Control and Prevention (CDC) reported today.
Apr 4, 2013
Apr 2, 2013
Mar 29, 2013
(CIDRAP News) – One of the key markers the US Centers for Disease Control and Prevention (CDC) uses to gauge flu activity returned to baseline last week for the first time since early December, signaling that the season is drawing to a close, the agency said today.
(CIDRAP News) – The nation's flu indicators continue to drop with the start of spring, but virus activity is still significant in many parts of the country, the US Centers for Disease Control and Prevention (CDC) said in its most recent surveillance report.
(CIDRAP News) – Flu activity in the United States last week continued its slow retreat, with more areas of the country returning to regional baselines and fewer respiratory samples testing positive for the virus.
Mar 8, 2013
(CIDRAP News) – Influenza activity in the United States continued to tumble last week, with one key marker—clinic visits for flulike illness—nearly approaching the national baseline, the US Centers for Disease Control and Prevention (CDC) said today.
